DataMeds AI (MEDS) Assets (2023 - 2026)

DataMeds AI (MEDS) has reported Assets for 4 consecutive years, with $30.1 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Assets fell 48.11% year-over-year to $30.1 million; the trailing twelve-month figure through Mar 2026 stood at $30.1 million (down 48.11% YoY), and the FY2025 full-year result was $30.5 million, down 46.87% from the prior year.
• Assets retreated to $30.1 million in Q1 2026 per MEDS's latest filing, from $30.5 million in the prior quarter.
• Across five years, Assets topped out at $58.1 million in Q1 2025 and bottomed at $338364.0 in Q4 2023.
• Historically, Assets has averaged $40.5 million across 4 years, with a median of $52.8 million in 2025.
• The sharpest annual moves came in 2024 and 2026: Assets surged 16844.08% in 2024, then tumbled 48.11% in 2026.
• Over 4 years, Assets stood at $338364.0 in 2023, then soared by 16844.08% to $57.3 million in 2024, then plunged by 46.87% to $30.5 million in 2025, then fell by 1.09% to $30.1 million in 2026.
• According to Business Quant data, Assets over the past three periods registered $30.1 million, $30.5 million, and $52.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.